<DOC>
	<DOCNO>NCT00447564</DOCNO>
	<brief_summary>Buprenorphine ( BPN ) approve treatment opioid dependence , however , take oral tablet , patient experience withdrawal craving variable BPN level blood low . Probuphine implant place beneath skin contain BPN . It design provide 6 month stable BPN blood level . This study test safety efficacy Probuphine treatment patient opioid dependence .</brief_summary>
	<brief_title>Safety Efficacy Probuphine Treatment Opioid Dependence</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Voluntarily provide write informed consent prior conduct study relate procedure Male female , 1865 year age Meet DSMIV criterion current opioid dependence Females childbearing potential fertile male must use reliable mean contraception Current diagnosis Acquired Immune Deficiency Syndrome ( AIDS ) Presence aspartate aminotransferase ( AST ) level ≥ 3 X upper limit normal and/or alanine aminotransferase ( ALT ) level ≥ 3 X upper limit normal and/or total bilirubin ≥ 1.5 X upper limit normal and/or creatinine ≥ 1.5 X upper limit normal Received treatment opioid dependence ( e.g. , methadone , BPN ) , within previous 90 day Current diagnosis chronic pain require opioids treatment Candidates short term opioid treatment opioid detoxification therapy Pregnant lactating female Previous hypersensitivity allergy BPN EVAcontaining substances naloxone Current use agent metabolize CYP 3A4 azole antifungal ( e.g. , ketoconazole ) , macrolide antibiotic ( e.g. , erythromycin ) , protease inhibitor ( e.g. , ritonavir , indinavir , saquinavir ) Current anticoagulant therapy ( warfarin ) INR &gt; 1.2 Meet DSMIV criterion current dependence psychoactive substance opioids nicotine ( e.g. , alcohol , sedative ) Current use benzodiazepine physician prescribe use Significant medical psychiatric symptom dementia opinion Investigators would preclude compliance protocol , patient safety , adequate cooperation study , obtain informed consent Concurrent medical condition ( severe respiratory insufficiency ) may prevent patient safely participate study ; and/or pending legal action could prohibit participation and/or compliance study Participated clinical study within previous 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>opioid addiction</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>methadone</keyword>
	<keyword>heroin</keyword>
	<keyword>implant</keyword>
	<keyword>opioid withdrawal</keyword>
	<keyword>opioid pain medication</keyword>
	<keyword>suboxone</keyword>
</DOC>